<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <title>Biobank | LiquidMammo™</title>

  <meta name="description" content="The MultiOmics Biobank supports LiquidMammo discovery and validation with longitudinal breast-cancer samples dating back to 2008, enabling rapid, retrospective performance testing of microRNA-based panels." />
  <meta name="theme-color" content="#E91E63" />

  <!-- Styles -->
  <link rel="stylesheet" href="assets/css/styles.css" />

  <!-- Favicon (place /favicon.png at repo root) -->
  <link rel="icon" href="favicon.png" type="image/png" />

  <!-- Social sharing -->
  <meta property="og:title" content="MultiOmics Biobank | LiquidMammo™" />
  <meta property="og:description" content="Longitudinal breast-cancer biobank (since 2008) enabling retrospective validation of microRNA diagnostic panels." />
  <meta property="og:image" content="assets/logos/liquidmammo-logo.png" />
  <meta property="og:type" content="website" />
</head>

<body>

<!-- Site header (copied from index for consistency) -->
<header class="container">
  <nav>
    <div class="brand">
      <img src="assets/logos/liquidmammo-logo.png" alt="LiquidMammo logo" />
      <strong>LiquidMammo™</strong>
    </div>
    <div style="display:flex;gap:14px;flex-wrap:wrap">
      <a href="how-it-works.html">How It Works</a>
      <a href="science.html">Science</a>
      <a href="patients.html">Patients</a>
      <a href="clinicians.html">Clinicians</a>
      <a href="evidence.html">Evidence</a>
      <a href="biobank.html">Biobank</a>
      <a href="pricing.html">Pricing</a>
      <a href="contact.html">Contact</a>
      <a href="privacy.html">Privacy</a>
    </div>
  </nav>
</header>

<main>

  <!-- Hero -->
  <section class="hero">
    <div class="container grid grid-2">
      <div>
        <h1>MultiOmics Biobank</h1>
        <p class="kicker">Longitudinal samples to accelerate clinical validation</p>
        <p class="small">
          Our breast‑cancer biobank includes longitudinally profiled participants, enabling
          retrospective performance assessment of microRNA‑based screening panels without waiting
          for long prospective outcomes.
        </p>
        <div style="margin-top:10px">
          <a class="btn" href="#access">Request Access</a>
          <a class="btn secondary" href="#governance">Governance</a>
        </div>
      </div>
      <div aria-hidden="true">
        <div class="card">
          <h3>At a glance</h3>
          <ul class="list-tight">
            <li><strong>Scope:</strong> Breast‑cancer biobank with longitudinal follow‑up</li>
            <li><strong>Retrospective depth:</strong> Cohorts dating back to 2008</li>
            <li><strong>Primary use:</strong> Discovery & validation of microRNA diagnostic panels</li>
            <li><strong>Data governance:</strong> Consent‑driven, with scientific & ethics review</li>
          </ul>
        </div>
      </div>
    </div>
  </section>

  <!-- Stats / Proof points -->
  <section class="container section">
    <h2>What makes this resource unique</h2>
    <div class="grid grid-2">
      <div class="card">
        <h3>Scale and history</h3>
        <p>
          The MultiOmics Biobank includes <strong>~20,000 breast‑cancer samples</strong> with
          <strong>longitudinal data</strong> allowing immediate, retrospective validation of
          candidate signatures. This depth supports rapid iteration of diagnostic panels by
          linking molecular signals to known outcomes.
        </p>
        <!-- Source: internal deck/email -->
        <!-- Biobank: ~20,000 samples; longitudinal since 2008 -->
      </div>
      <div class="card">
        <h3>Consent & provenance</h3>
        <p>
          The DNA consent pathway was <strong>originally developed at Baylor</strong>, and
          <strong>ownership resides with MultiOmics</strong>. Consent and governance are structured
          to enable research while protecting participant rights and privacy.
        </p>
        <!-- Source: internal deck/email referencing Baylor & ownership -->
      </div>
    </div>
  </section>

  <!-- What’s collected / linked data (kept general to avoid over‑specifying) -->
  <section class="container section">
    <h2>What we bank</h2>
    <div class="grid grid-2">
      <div class="card">
        <h3>Specimens</h3>
        <p>
          The biobank supports liquid‑biopsy discovery and validation, focusing on blood‑based
          materials suitable for microRNA profiling. Where available, paired tissue and other
          clinical specimens are linked to support biology‑aware models.
        </p>
        <p class="small">
          Detailed specimen‑handling SOPs are shared under an approved access request and are updated
          periodically to reflect best practice in pre‑analytical quality control.
        </p>
      </div>
      <div class="card">
        <h3>Linked clinical data</h3>
        <p>
          Longitudinal clinical context (e.g., diagnosis, subtype assignment, imaging/biopsy
          confirmation, and time‑to‑event variables when available) supports high‑fidelity
          label definition for training and validating diagnostic algorithms.
        </p>
        <p class="small">
          Variables and data dictionaries are provided on approval; all datasets are de‑identified
          prior to release.
        </p>
      </div>
    </div>
  </section>

  <!-- How it’s used -->
  <section class="container section">
    <h2>How investigators use the biobank</h2>
    <div class="grid grid-2">
      <div class="card">
        <h3>Discovery</h3>
        <p>
          Identify candidate microRNA signatures associated with breast‑cancer presence and
          molecular subtype; optimize signal processing, normalization, and feature selection.
        </p>
      </div>
      <div class="card">
        <h3>Retrospective validation</h3>
        <p>
          Quantify diagnostic performance (sensitivity, specificity, AUC) using historical samples
          with known outcomes to reduce risk ahead of prospective studies.
        </p>
      </div>
    </div>
  </section>

  <!-- Governance -->
  <section id="governance" class="container section">
    <h2>Governance & participant protections</h2>
    <div class="grid grid-2">
      <div class="card">
        <h3>Consent & privacy</h3>
        <p>
          All access is consent‑driven. Requests undergo a documented review that includes
          scientific merit, data‑minimization, and privacy safeguards. Only de‑identified data
          are released to external investigators.
        </p>
      </div>
      <div class="card">
        <h3>Scientific & ethics review</h3>
        <p>
          External requests are evaluated for feasibility, analytic rigor, and alignment with
          participant consent. Results generated from biobank data are expected to be shared
          back for reproducibility.
        </p>
      </div>
    </div>
  </section>

  <!-- Access process -->
  <section id="access" class="container section">
    <h2>Accessing the biobank</h2>
    <div class="grid grid-2">
      <div class="card">
        <h3>Who can apply</h3>
        <p>
          Academic, clinical, or industry researchers with a cancer‑diagnostics focus. We
          prioritize studies that improve early detection, address dense‑breast limitations,
          or clarify subtype‑specific pathways.
        </p>
      </div>
      <div class="card">
        <h3>How to request</h3>
        <ol class="list-tight">
          <li>Submit a short concept (<em>2–3 pages</em>) with aims, endpoints, and dataset needs.</li>
          <li>Provide IRB status (if applicable) and data‑security plan.</li>
          <li>Agree to data‑use terms and attribution language.</li>
        </ol>
        <div style="margin-top:10px">
          <a class="btn" href="contact.html">Start a Request</a>
          <a class="btn secondary" href="privacy.html">Data Use & Privacy</a>
        </div>
      </div>
    </div>
  </section>

  <!-- FAQ -->
  <section class="container section">
    <h2>Frequently asked</h2>
    <div class="grid grid-2">
      <div class="card">
        <h3>Do you share raw or processed data?</h3>
        <p>
          Both can be supported depending on consent and review. For discovery, raw plus minimal


